Palliative care for diffuse large B-cell lymphoma has significantly improved over the past several years, but disparities ...

"Epcoritamab and R 2 is a novel chemotherapy-free fixed-duration therapy that is suitable for outpatient administration and, we believe, sets a new benchmark as a standard of care for second-line [or ...

Mr Markle, 81, who has been estranged from his daughter since her wedding to Prince Harry, was admitted to a hospital in Cebu ...

Meghan Markle's father, Thomas Markle, was in the hospital after a recent health crisis that had him undergo emergency ...

Patients with <7/8 transplants had a 1-year survival of 85.6% versus 78.6% for those who received better-matched donor cells.

Thomas Markle, 81, appealed to the Duchess of Sussex to see him 'one more time before I die' as he lay in his hospital bed ...

Among older patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL), treatment with fixed-duration Epkinly (epcoritamab-bysp) plus dose-attenuated Rituxan (rituximab) plus cyclophosphamide ...

IV iron administration has historically been a “controversial issue” for treatment of iron deficiency anemia during acute ...

Epcoritamab combined with R-mini-CHOP showed a 93% overall response rate in elderly DLBCL patients, with 86% achieving complete response. At two years, 79% of patients remained in response, and 90% ...

Nasasabik ang Filipino staff ng isang ospital sa Cebu City sa posibilidad na makita nila nang personal ang Duchess of Sussex ...

Kite, a Gilead Company , presented a new analysis today demonstrating that second-line Yescarta® (axicabtagene ciloleucel) therapy offers consistent benefits in patients with relapsed/refractory large ...

One study found frail patients tend to have worse survival outcomes on the therapy, but another challenged the idea that ...